Patent classifications
A61B5/6869
Method and medical device for discriminating between a supraventricular tachycardia and a ventricular tachycardia
A method for automatically discriminating between a supraventricular tachycardia event and a ventricular tachycardia event is provided. The method includes sensing a first cardiac signal using a first electrode pair and a second cardiac signal using a second electrode pair during a heartbeat, applying a first algorithm to the first cardiac signal to determine whether the first cardiac signal is indicative for a supraventricular tachycardia or indicative for the ventricular tachycardia; applying a second algorithm to the second cardiac signal to determine whether the second cardiac signal is indicative for the supraventricular tachycardia or indicative for the ventricular tachycardia, the second comparison algorithm being different from the first comparison algorithm; and assigning to a heartbeat-specific indicator a first value indicative for the ventricular tachycardia when at least one of the first cardiac signal and the second cardiac signal have been determined to be indicative tor the ventricular tachycardia.
METHOD FOR CALCULATING INSTANTANEOUS WAVE-FREE RATIO BASED ON PRESSURE SENSOR AND ANGIOGRAM IMAGES
Disclosed is a method for calculating an instantaneous wave-free ratio based on a pressure sensor and angiogram images, comprising: acquiring pressures at the coronary artery ostium of heart by a blood pressure sensor in real-time, and storing the pressure values in a data linked table, and the data linked table being indexed by time and the time and real-time pressure being saved in the form of key-value pairs; finding out corresponding datas from the data queue based on time index using the angiography time as an index value, taking an average value of four wave-free pressure values as a wave-free pressure value Pa; obtaining a time Tn of an end phase of a diastolic period, namely of a wave-free period within one cycle according to the time index within the cycle; obtaining a length L of a segment of a blood vessel through angiogram images of two body positions, and obtaining a blood flow velocity V; calculating a pressure drop ΔP and calculating a pressure Pd which at the distal end of the blood vessel as Pd=Pa−ΔP, and further obtaining the instantaneous wave-free ratio.
DIRECT CARDIAC PRESSURE MONITORING
A septal closure device includes a frame comprising one or more tissue anchor features, an occluding membrane, and a pressure sensor device attached to the occluding membrane.
CARDIAC IMPLANT DEVICES WITH INTEGRATED PRESSURE SENSING
A sensor implant device includes a shunt structure comprising a flow path conduit and a plurality of arms configured to secure the shunt structure to a tissue wall, and a pressure sensor device attached to one of the plurality of arms of the shunt structure. The pressure sensor device comprises one or more sensor elements, an antenna, control circuitry electrically coupled to the one or more sensor elements and the antenna, and a housing that houses the control circuitry.
Wireless MEMS left atrial pressure sensor
Systems for monitoring left atrial pressure using implantable cardiac monitoring devices and, more specifically, to a left atrial pressure sensor implanted through a septal wall are presented herein.
Determining catheter touch location using force-vector information
A system includes an electrical interface for communicating with a probe, and a processor. The electrical interface is configured to be inserted into a heart of a patient. The processor is configured to (A) receive from the probe, via the electrical interface, (i) position-signals indicative of a position of a distal tip of the probe in the heart, (ii) a contact-force indication indicative of a contact force exerted on the distal tip, and (iii) an electrophysiological (EP) measurement acquired by the distal tip at the position, (B) calculate a contact-force vector based on the contact-force indication received from the distal tip, and (C) based on the position-signals and on the contact-force vector, estimate a location, on an electro-anatomical map of the heart, at which the distal tip touches tissue, and to update the electro-anatomical map with the EP measurement, associated with the estimated location.
SYSTEMS AND METHODS FOR SELECTING, ACTIVATING, OR SELECTING AND ACTIVATING TRANSDUCERS
Transducer-based systems can be configured to display a graphical representation of a transducer-based device, the graphical representation including graphical elements corresponding to transducers of the transducer-based device, and also including between graphical elements respectively associated with a set of the transducers and respectively associated with a region of space between the transducers of the transducer-based device. Selection of graphical elements and/or between graphical elements can cause activation of the set of transducers associated with the selected elements. Selection of a plurality of graphical elements and/or between graphical elements can cause visual display of a corresponding activation path in the graphical representation. Visual characteristics of graphical elements and between graphical elements can change based on an activation-status of the corresponding transducers. Activation requests for a set of transducers can be denied if it is determined that a transducer in the set of transducers is unacceptable for activation.
MANAGING COMMUNICATION INTERFERENCE IN LEADLESS DUAL-CHAMBER PACING SYSTEMS AND OTHER IMD SYSTEMS
Embodiments described herein relate to implantable medical devices (IMDs) and methods for use therewith. Such a method includes, during each of a plurality of message alert periods during which a communication capability of the IMD is enabled, determining whether a valid message is detected. In response to determining that no valid message was detected during a message alert period, the communication capability of the IMD is temporarily disable for a disable period. A length of the disable period may be increased in response to no valid message being detected during two consecutive message alert periods. A length of the disable period may be dependent on an operational mode of the IMD, such that the length of the disable period differs for different operational modes. The IMD may also enter a noise state, and remain in the noise state until the IMD receives a specified number of valid messages.
SNARE-INTEGRATED MYOCARDIAL ELECTRICAL SIGNAL-DETECTING CATHETER
A snare-integrated myocardial electrical signal-detecting catheter is proposed. The snare-integrated myocardial electrical signal-detecting catheter enables a cerclage wire to pass through the His bundle by way of detecting an electrical signal from the myocardium, and safely guides the cerclage wire into a patient's body by capturing the cerclage wire, which has passed through the His bundle, with a snare built in the catheter. The snare-integrated myocardial electrical signal-detecting catheter includes: a catheter having a hollow space to insert a guidewire thereinto, and having a distal part thereof coupled to at least one or more electrodes to detect an electrical signal of the myocardium; a snare lumen built along a longitudinal direction in a sidewall of the catheter, and having a hollow space therein; and a snare inserted into the snare lumen and having one end thereof provided with at least one or more annular wires.
SYSTEM FOR VERIFYING A PATHOLOGIC EPISODE USING AN ACCELEROMETER
A system for verifying a candidate pathologic episode of a patient is provided. The system includes an accelerometer configured to be implanted in the patient, the accelerometer configured to obtain accelerometer data along at least one axis. The system also includes a memory configured to store program instructions and one or more processors. When executing the program instructions, the one or more processors are configured to obtain a biological signal and identify a candidate pathologic episode based on the biological signal, analyze the accelerometer data to identify a physical action experienced by the patient, and verify the candidate pathologic episode based on the physical action.